Abbott Laboratories
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$50.9M
12 notices · 447,292 sh
Oct 2025 to Oct 2026
Reported ·
$688,360
7 sales · 6 buys · $4,402,807 bought
Oct 2025 to Jun 2026
The two figures cover different periods.
None of the 7 reported sales carry the 10b5-1 box. Together they are under 0.01% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-09-02John A. McCoy, Jr., VICE PRESIDENT AND CONTROLLER$2,957
2026-08-25Robert B. Ford, CHAIRMAN AND CEO$46.2M
2026-08-11Louis H. Morrone, EXECUTIVE VICE PRESIDENT$642,506
2026-05-15Robert J. Alpern, Retired Director$646,791
2026-04-27Robert J. Alpern, Retired Director$2,703,457
2026-03-02Elizabeth C. Cushman, EVP, GC AND SECRETARY$30,397
Form 4, 2026-03-03: sold 263 at $115.58 Form 4 ↗
2026-03-02Eric Shroff, Senior Vice President$81,946
Form 4, 2026-03-03: sold 709 at $115.58 Form 4 ↗
2026-03-02Louis H. Morrone, EXECUTIVE VICE PRESIDENT$132,223
Form 4, 2026-03-03: sold 1,144 at $115.58 Form 4 ↗
2026-03-02Mary K. Moreland, EXECUTIVE VICE PRESIDENT$70,850
Form 4, 2026-03-03: sold 613 at $115.58 Form 4 ↗
2026-03-02John A. McCoy, Jr., VICE PRESIDENT AND CONTROLLER$67,614
Form 4, 2026-03-03: sold 585 at $115.58 Form 4 ↗
2026-03-02Daniel Gesua Sive Salvadori, EVP AND GROUP PRESIDENT$102,288
Form 4, 2026-03-03: sold 885 at $115.58 Form 4 ↗